Clinical Trials Logo

Clinical Trial Summary

To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)


Clinical Trial Description

In order to confirm the promising results of the 36 Gy dose level in the DOREMY trial (NCT02106312) and to compare outcome with other local treatment approaches. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04699292
Study type Observational [Patient Registry]
Source The Netherlands Cancer Institute
Contact Rick Haas, MD/PhD
Phone +31 20 512 9111
Email r.haas@nki.nl
Status Recruiting
Phase
Start date January 18, 2021
Completion date January 2031

See also
  Status Clinical Trial Phase
Terminated NCT01957709 - Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma Early Phase 1
Active, not recruiting NCT03600649 - Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas Phase 1
Completed NCT02821507 - Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma Phase 2
Withdrawn NCT03397186 - Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma Phase 2
Active, not recruiting NCT03989596 - Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas Phase 2
Enrolling by invitation NCT05266196 - A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) Phase 1/Phase 2
Recruiting NCT05492682 - START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer Phase 1
Active, not recruiting NCT03651375 - Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall Phase 2
Active, not recruiting NCT00633165 - Brostallicin Clinical Trial for Myxoid Liposarcoma Phase 2
Recruiting NCT04044768 - Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Phase 2
Active, not recruiting NCT03816475 - Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial) Phase 2